Pulling SEC filings + quote and writing the call…
CADL
Candel Therapeutics, Inc.
Next earnings Aug 12, 2026 · consensus $-0.24 EPS
Last earnings -0.3% on 2026-05-14
$9.15
▲ +10.11%$9.15▲ +77.33%
over 1Y
L $4.42EODHDH $9.27
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+10.1%
1W+6.9%
1M+15.1%
3M+83.4%
YTD+68.2%
1Y+77.3%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 15 analysts
Buy
Unprofitable (net margin -30545.6%).
Candel Therapeutics, Inc. shows $125K in FY2022 revenue (+0.0% YoY), a -30545.6% net margin, and -73.5% ROE.
Sources: SEC EDGAR (CIK 0001841387, latest 10-Q filed 2026-05-14) · EODHD · as of 6/22/2026, 11:32:05 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.